Literature DB >> 19009713

Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.

Michael L Volk1, Anna S F Lok, Shawn J Pelletier, Peter A Ubel, Rodney A Hayward.   

Abstract

BACKGROUND & AIMS: Although priority for liver transplantation is determined by the model for end-stage liver disease (MELD) score, the quality of organs used is subject to physician discretion. We aimed to determine whether implementation of MELD affected the quality of organs transplanted, the type of patients who receive the higher-risk organs, and the impact of these changes on their posttransplant survival.
METHODS: Data were analyzed from the United Network for Organ Sharing of adults who underwent deceased-donor liver transplantation between January 1, 2007, and August 1, 2007 (n = 47,985). Dependent variables included the donor risk index (a continuous variable that measures the risk of graft failure associated with a particular organ) and patient survival after transplantation.
RESULTS: The overall organ quality of transplanted livers has worsened since MELD implementation, with an increase in the donor risk index equivalent to a 4% increased risk of graft failure after adjusting for temporal trends (P < .001). This was accompanied by a shift from using the higher-risk organs in the more urgent patients (in the pre-MELD era) to using the higher-risk organs in the less urgent patients (in the post-MELD era). Posttransplant survival has worsened over time (hazard ratio, 1.017/y; P = .005) among the less urgent patients (MELD scores, <20); mediation analysis suggests this change in survival was caused primarily by changes in organ quality.
CONCLUSIONS: As an unintended consequence of the MELD allocation policy, patients that are least in need of a liver transplant now receive the highest-risk organs. This has reduced posttransplant survival in recent years among patients with low MELD scores.

Entities:  

Mesh:

Year:  2008        PMID: 19009713     DOI: 10.1053/j.gastro.2008.08.003

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  Development of organ-specific donor risk indices.

Authors:  Sanjeev K Akkina; Sumeet K Asrani; Yi Peng; Peter Stock; W Ray Kim; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

Review 2.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 3.  Transplant for the very sick: No limitations in donor quality?

Authors:  Jennifer C Lai
Journal:  Liver Transpl       Date:  2017-10       Impact factor: 5.799

Review 4.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

5.  D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation.

Authors:  Jeffrey B Halldorson; Robert L Carithers; Renuka Bhattacharya; Ramasamy Bakthavatsalam; Iris W Liou; Andre A Dick; Jorge D Reyes; James D Perkins
Journal:  World J Transplant       Date:  2014-09-24

Review 6.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

7.  Factors Associated With Short- and Long-term Liver Graft Survival in the United Kingdom: Development of a UK Donor Liver Index.

Authors:  David Collett; Peter J Friend; Christopher J E Watson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 8.  Organ allocation for chronic liver disease: model for end-stage liver disease and beyond.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Curr Opin Gastroenterol       Date:  2010-05       Impact factor: 3.287

9.  Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'.

Authors:  Lucas McCormack; Emilio Quiñonez; María Martha Ríos; Pablo Capitanich; Nicolás Goldaracena; Javier Kerman Cabo; Margarita Anders; Javier Osatnik; Pablo Comignani; Norberto Mezzadri; Ricardo Cesar Mastai
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

Review 10.  Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.

Authors:  Mohamad R Al Sibae; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.